MYQINDRO Trademark

Trademark Overview


On Wednesday, August 7, 2024, a trademark application was filed for MYQINDRO with the United States Patent and Trademark Office. The USPTO has given the MYQINDRO trademark a serial number of 98687168. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 18, 2025. This trademark is owned by Faraday Pharmaceuticals, Inc.. The MYQINDRO trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the prevention and treatment of cardiac and skeletal muscle function diseases and disorders

Providing a website featuring information concerning medical diagnosis and treatment of cardiac and skeletal muscle function diseases and disorders

Providing a website featuring information in the field of testing of pharmaceuticals; providing a website featuring information concerning medical research in the field of cardiac and skeletal muscle function diseases and disorders; research and development in the field of pharmaceuticals

General Information


Serial Number98687168
Word MarkMYQINDRO
Filing DateWednesday, August 7, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of cardiac and skeletal muscle function diseases and disorders
Goods and ServicesProviding a website featuring information concerning medical diagnosis and treatment of cardiac and skeletal muscle function diseases and disorders
Goods and ServicesProviding a website featuring information in the field of testing of pharmaceuticals; providing a website featuring information concerning medical research in the field of cardiac and skeletal muscle function diseases and disorders; research and development in the field of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 19, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 19, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFaraday Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Party NameFaraday Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Trademark Events


Event DateEvent Description
Wednesday, August 7, 2024NEW APPLICATION ENTERED
Wednesday, January 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 13, 2025ASSIGNED TO EXAMINER
Friday, February 21, 2025EXAMINERS AMENDMENT -WRITTEN
Friday, February 21, 2025EXAMINERS AMENDMENT E-MAILED
Friday, February 21, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 21, 2025EXAMINER'S AMENDMENT ENTERED
Monday, February 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED